ALK-Positive Lung Cancer Drug “Ceritinib(LDK378)”

Page 1

www.aasraw.com

ALK-Positive Lung Cancer Drug “Ceritinib(LDK378)”

ALK-Positive Lung Cancer Drug “Ceritinib(LDK378)”.............................................................................. 1 CeritinibWasApprovedForUsinginEU................................................................................................2 CeritinibDescription..........................................................................................................................2 HowDoesCeritinibWorkForTreatingNSCLC?.......................................................................................3 HowAboutCeritinibMedicalUses?.....................................................................................................3 HowToStorageCeritinib(LDK378)?......................................................................................................4 WhatIsSideEffectsOfCeritinib?.........................................................................................................4 WhatOtherBenefitsOfCeritinibHaveBeenShownInStudies?................................................................6 CeritinibGetsFirst-LineFDAApprovalforALK-PositiveLungCancer............................................................7 Reference............................................................................................................................... 8

1

AASraw Biochemical Technology Co.,Ltd aas14@aasraw.com


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.